Offerings - Offering: 1 |
Jul. 31, 2026
USD ($)
|
|---|---|
| Offering: | |
| Fee Previously Paid | true |
| Rule 457(o) | true |
| Security Type | Equity |
| Security Class Title | Class A Common Stock, $0.01 par value per share |
| Maximum Aggregate Offering Price | $ 1,000,000,000 |
| Amount of Registration Fee | $ 0 |
| Carry Forward Form Type | S-3 |
| Carry Forward File Number | 333-273784 |
| Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward | $ 116,350 |
| Offering Note | Healthcare Realty Trust Incorporated (the “Company”) previously registered shares of common stock having an aggregate offering price of up to $750,000,000, offered by means of a prospectus supplement, dated March 5, 2021 (the “2021 Prospectus Supplement”), pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-253600), filed with the Securities and Exchange Commission on February 26, 2021 (the “2021 Registration Statement”). In connection with the filing of the 2021 Prospectus Supplement, the Company made a contemporaneous fee payment to the SEC in the amount of $81,825. All such shares remained unsold and were carried forward to the Company’s Registration Statement on Form S-3 (File No. 333-273784), filed with the SEC on August 8, 2023 (the “2023 Registration Statement”) pursuant to Rule 415(a)(6). On December 17, 2025, the Company registered shares of common stock having an aggregate offering price of up to $1,000,000,000, offered by means of a prospectus supplement, dated December 17, 2025 (the “2025 Prospectus Supplement”), pursuant to the 2023 Registration Statement, of which shares having an aggregate offering price of $750,000,000 represented unsold securities previously registered pursuant to the 2021 Prospectus Supplement and the 2021 Registration Statement. In connection with the filing of the 2025 Prospectus Supplement, the Company made a contemporaneous fee payment in the amount of $34,525, reflecting the fee due with respect to shares of common stock to be offered and sold pursuant to the 2025 Prospectus Supplement that were not unsold securities registered pursuant to the 2021 Prospectus Supplement and the 2021 Registration Statement. Pursuant to Rule 415(a)(6) under the Securities Act, the securities with an aggregate offering price of $1,000,000,000 (collectively, the “Carry Forward Securities”) are unsold securities previously registered on the 2023 Registration Statement, for which filing fees of $116,350, in the aggregate, were previously paid to the Securities and Exchange Commission on the dates described above and will continue to be applied to such Carry Forward Securities. Pursuant to Rule 415(a)(6), the offering of the Carry Forward Securities under the 2023 Registration Statement was deemed terminated as of the immediate effectiveness of the Company's new registration statement on Form S-3ASR (File No. 333-297897) filed with the SEC on July 31, 2026. As a result, no additional filing fee is due. |